NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

You said, for instance, in one of many posts:

“the reclassification by WHO, just gave NWBO another possible ad hoc set of calculations to see if they would work.

In other words, the fact that this new classification had the blessing of WHO, and is mot merely the result of NWBO data mining, does not make the new calculation ant less ad hoc.”

Excuse… you said NWBO now has an excuse to take an ad hoc approach, that implicitly makes this some bogus thing that NWBO is doing. Those are not my words, that is the general gist of your statement.

I merely said that it’s not an excuse, effectively, they MUST respond and have an answer to the redefinition because it is the regulators job to ask about this and it is their job to have answers. Period. It’s not a tactic, it’s not some excuse to take an ad hoc or post hoc analysis. It is necessary to get the license to treat the condition that has now been redefined by everyone else, including the regulator, who will certainly ask about this issue, it is not some irrelevant new thing they are bringing in because it helps them. It is not some tangent, and it is not inexplicably damaging for them to ensure they have the data and the answer to a question they know will be highly pertinent to the regulator, even though it actually happens to help them.

Turning random changes or even good things into bad things is one of those things that happens on bulletin boards. Unfortunately. People worry a lot, I guess.